ESSAI D'ANDROGENOTHERAPIE DANS LE TRAITEMENT DES LEUCEMIES AIGUES NON LYMPHOBLASTIQUES DE L'ENFANT. PREMIERS RESULTATS.POIROT P; POUZOL P; SOTTO JJ et al.1978; PEDIATRIE; FR.; DA. 1978; VOL. 33; NO 1; PP. 89-97; ABS. ANGL.; BIBL. 10 REF.Article

STANOZOLOL IN POSTMENOPAUSAL OSTEOPOROSIS: THERAPEUTIC EFFICACY AND POSSIBLE MECHANISMS OF ACTIONCHESTNUT CH III; IVEY JL; GRUBER HE et al.1983; METABOLISM, CLINICAL AND EXPERIMENTAL; ISSN 0026-0495; USA; DA. 1983; VOL. 32; NO 6; PP. 571-580; BIBL. 32 REF.Article

Neurochemical consequence of steroid abuse: Stanozolol-induced monoaminergic changesTUCCI, Paolo; GRAZIA MORGESE, Maria; COLAIANNA, Marilena et al.Steroids. 2012, Vol 77, Num 3, pp 269-275, issn 0039-128X, 7 p.Article

STUDIES ON THE METABOLIC MECHANISM OF REDUCED HIGH DENSITY LIPOPROTEINS DURING ANABOLIC STEROID THERAPYHAFFNER SM; KUSHWAHA RS; FOSTER DM et al.1983; METABOLISM, CLINICAL AND EXPERIMENTAL; ISSN 0026-0495; USA; DA. 1983; VOL. 32; NO 4; PP. 413-421; BIBL. 47 REF.Article

Stanozolol-induced changes in fibrinolysis and coagulation in healthy adultsKLUFT, C; PRESTON, F. E; MALIA, R. G et al.Thrombosis and haemostasis. 1984, Vol 51, Num 2, pp 157-164, issn 0340-6245Article

Analysis of anabolic steroids in human hair using LC-MS/MSDESHMUKH, Nawed; HUSSAIN, Iltaf; BARKER, James et al.Steroids. 2010, Vol 75, Num 10, pp 710-714, issn 0039-128X, 5 p.Article

DETECTION AND QUANTITATION OF STANOZOLOL (STROMBA^REG.) IN URINE BY ISOTOPE DILUTION-MASS FRAGMENTOGRAPHYLANTTO O; BJORKHEIM I; EK H et al.1981; J. STEROID BIOCHEM.; ISSN 0022-4731; GBR; DA. 1981; VOL. 14; NO 8; PP. 721-727; BIBL. 8 REF.Article

THE EFFECT OF THE ANABOLIC STEROID STANOZOLOL ON TISSUE PLASMINOGEN ACTIVATOR ACTIVITY AND PLASMIN INHIBITION IN THE RATSMOKOVITIS A; BINDER BR.1980; EXPERIENTIA; ISSN 0014-4754; CHE; DA. 1980; VOL. 36; NO 9; PP. 1079-1080; BIBL. 19 REF.Article

Stanozolol in the treatment of pityriasis rubra pilarisPAVLIDAKEY, G. P; HASHIMOTO, K; SAVOY, L. B et al.Archives of dermatology (1960). 1985, Vol 121, Num 4, pp 546-548, issn 0003-987XArticle

Protein C, an anticoagulant protein, is increased in healthy volunteers and surgical patients after treatment with stanozololKLUFT, C; BERTINA, R. M; PRESTON, F. E et al.Thrombosis research. 1984, Vol 33, Num 3, pp 297-304, issn 0049-3848Article

REDUCTION IN HIGH DENSITY LIPOPROTEINS BY ANABOLIC STEROID (STANOZOLOL) THERAPY FOR POSTMENOPAUSAL OSTEOPOROSISTAGGART HM; APPLEBAUM BOWDEN D; HAFFNER S et al.1982; METAB. CLIN EXP.; ISSN 0026-0495; USA; DA. 1982; VOL. 31; NO 11; PP. 1147-1152; BIBL. 36 REF.Article

ANALYSE ET TECHNOLOGIE DE LA COMPRESSION DE L'ANDROSTANAZOLENOVIKOVA NV; KUZ'MENKO II; KULESH KF et al.1978; FARMACIJA; SUN; DA. 1978; NO 5; PP. 18-21; ABS. ENG; BIBL. 4 REF.Article

ATHLETES AND ANABOLIC STEROIDS.1977; DRUG THERAPEUT. BULL.; G.B.; DA. 1977; VOL. 15; NO 11; PP. 43-44; BIBL. 14 REF.Article

FIBRINOLYTIC AGENTS IN THE TREATMENT OF NECROBIOSIS LIPOIDICA.RHODES EL.1976; BRIT. J. DERMATOL.; G.B.; DA. 1976; VOL. 95; NO 6; PP. 673-675; BIBL. 15 REF.Article

Stanozolol as a novel therapeutic agent in dermatologyHELFMAN, T; FALANGA, V.Journal of the American Academy of Dermatology. 1995, Vol 33, Num 2, pp 254-258, issn 0190-9622, 1Article

UNTERSUCHUNGEN UEBER DEN ¹³¹I-FIBRINOGENUMSATZ BEI DER AKTIVIERUNG DER BLUTFIBRINOLYSE. = ETUDES DE LA TRANSFORMATION DU FIBRINOGENE AU I 131 DANS L'ACTIVATION DE LA FIBRINOLYSE SANGUINEGRABOWSKI R; BIELAWIEC M; KIERSNOWSKA B et al.1976; Z. GES. INNERE MED.; DTSCH.; DA. 1976; VOL. 31; NO 24; PP. 1025-1027; ABS. RUSSE ANGL.; BIBL. 11 REF.Article

THE FIBRINOLYTIC RESPONSE TO STANOZOLOL IN NORMAL SUBJECTSPRESTON FE; BURAKOWSKI BK; PORTER NR et al.1981; THROMB. RES.; ISSN 0049-3848; USA; DA. 1981; VOL. 22; NO 5-6; PP. 543-551; BIBL. 21 REF.Article

JAUNDICE INDUCED BY STANOZOLOL HYPERSENSITIVITYSLATER SP; DAVIDSON TF; PATRICK RS et al.1976; POSTGRAD. MED. J.; G.B.; DA. 1976; VOL. 52; NO 606; PP. 229-232; BIBL. 13 REF.Article

AN INTEGRATED BIOASSAY FOR ANABOLIC-ANDROGENIC ACTIVITY. ITS APPLICATION TO STANOZOLOLVARGAS L; ABELIUK J.1972; STEROIDS LIPIDS RES.; SWITZ.; DA. 1972; VOL. 3; NO 6; PP. 353-362; BIBL. 1P.Article

The treatment of glucocorticosteroid-dependent chronic urticaria with stanozololBRESTEL, E. P; THRUSH, L. B.Journal of allergy and clinical immunology. 1988, Vol 82, Num 2, pp 265-269, issn 0091-6749Article

Oral stanozolol: effects on plasma and saliva fibrinolysis and plasma viscosity in normal malesSMALL, M; MCARDLE, B. M; LOWE, G. D. O et al.Thrombosis research. 1983, Vol 31, Num 2, pp 233-237, issn 0049-3848Article

Possible interaction of warfarin and stanozololSHAW, P. W; SMITH, A. M.Clinical pharmacy. 1987, Vol 6, Num 6, pp 500-502, issn 0278-2677Article

Metabolism of stanozolol : identification and synthesis of urinary metabolitesSCHAÊNZER, W; OPFERMANN, G; DONIKE, M et al.Journal of steroid biochemistry. 1990, Vol 36, Num 1-2, pp 153-174, issn 0022-4731, 22 p.Article

Prophylactic antithrombotic therapy with stanozolol in patients with familial antithrombin III deficiencyWINTER, J. H; FENECH, A; BENNETT, B et al.British journal of haematology. 1984, Vol 57, Num 3, pp 527-537, issn 0007-1048Article

ANDROGENES ET REMISSIONS PROLONGEES DANS LES LEUCEMIES AIGUES NON LYMPHOBLASTIQUES. RESULTATS D'UN TRAITEMENT SYSTEMATIQUE PAR LE STANOZOLOL ASSOCIE A LA CHIMIOTHERAPIESOTTO JJ; HOLLARD D; SCHAERER R et al.1975; NOUV. REV. FR. HEMATOL.; FR.; DA. 1975; VOL. 15; NO 1; PP. 57-72; ABS. ANGL.; BIBL. 2P.Article